Tag: IgG4-related disease

Inebilizumab reduces the risk of flares in IgG4-related disease

byNhat Hung (Benjamin) Lamand1 others

April 8, 2025

1. In this randomized controlled trial, inebilizumab, an anti-CD19 monoclonal antibody, reduced the risk of flares and increased the likelihood ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2 Minute Medicine Rewind June 23, 2025

No Result

View All Result